Company · CIK 1745114
MOLECULAR PARTNERS AG
| CIK | 1745114 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | V8 |
| Business address | Switzerland |
| Listed | MOLN (Nasdaq) |
| First annual or quarterly report | 2022-03-15 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-286488 | 2025-04-11 | 2025-04-24 | 2 | |
| 333-265960 | 2022-07-01 | 2024-10-25 | 3 | |
| 333-255447 | 2021-04-22 | 2021-06-16 | 8 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-04-24 | EFFECTDeclared effective | 333-286488 | 9999999995-25-001237 |
| 2025-04-11 | F-3Shelf registered | 333-286488 | 0001628280-25-017499 |
| 2024-10-25 | 424B5Shelf takedown | 333-265960 | 0001628280-24-043767 |
| 2022-07-12 | EFFECTDeclared effective | 333-265960 | 9999999995-22-002039 |
| 2022-07-01 | F-3Shelf registered | 333-265960 | 0001745114-22-000007 |
| 2021-06-16 | 424B4Final prospectus | 333-255447 | 0001628280-21-012362 |
| 2021-06-15 | EFFECTDeclared effective | 333-256924 | 9999999995-21-002357 |
| 2021-06-15 | EFFECTDeclared effective | 333-255447 | 9999999995-21-002343 |
| 2021-06-14 | F-1/AAmendment | 333-255447 | 0001628280-21-012129 |
| 2021-06-10 | F-1/AAmendment | 333-255447 | 0001628280-21-012036 |
| 2021-06-09 | F-1/AAmendment | 333-255447 | 0001628280-21-011854 |
| 2021-05-12 | F-1/AAmendment | 333-255447 | 0001628280-21-010041 |
| 2021-05-04 | F-1/AAmendment | 333-255447 | 0001628280-21-008917 |
| 2021-04-22 | F-1Registration filed | 333-255447 | 0001628280-21-007388 |
| 2021-03-15 | DRSDraft made public | 377-04414 | 0001628279-21-000163 |